Contracts › 75N94022F00001
75N94022F00001: The Goal of This Task Order Is to Perform Pharmacoepidemiology Research and a Pk, Pharmacodynamic, Pharmacogenomic, Efficiency, and Safety Trial of the Highest Recommended Dose of Sildenafil in Preterm Neonates (COHORT 3); With Clinically Relevant Ou
Awarded to Duke University by National Institutes of Health (NIH).
$1.5Mobligated
$1.5Mpotential value
14 February 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N94022F00001 |
|---|---|
| Vehicle | 75N94018D00003 |
| Awardee | Duke University |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NC |
| Period of performance | 14 June 2022 to 14 February 2027 |
| Potential end | 14 February 2027 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record